Mumbai, Sept. 23 -- Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:

1. Moxonidine 200 microgram Tablets

2. Moxonidine 400 microgram Tablets

Published by HT Digital Content Services with permission from Capital Market....